251 related articles for article (PubMed ID: 1343514)
1. [Evolution, capabilities and limits of psychopharmacology].
Ballús C
Ann Med Psychol (Paris); 1992; 150(2-3):175-80. PubMed ID: 1343514
[TBL] [Abstract][Full Text] [Related]
2. Riding the biological brain wave.
Stavig V
Minn Med; 1996 Jan; 79(1):14-8. PubMed ID: 8587554
[No Abstract] [Full Text] [Related]
3. Contemporary psychopharmacotherapy in the context of brave new psychiatry, well-being therapy and life coaching.
Jakovljević M
Psychiatr Danub; 2007 Sep; 19(3):195-201. PubMed ID: 17914319
[TBL] [Abstract][Full Text] [Related]
4. Evidence base for psychotherapy: two perspectives.
Clemens NA
J Psychiatr Pract; 2010 May; 16(3):183-6. PubMed ID: 20485107
[TBL] [Abstract][Full Text] [Related]
5. [Janus-faced therapy: what is common in psychotherapy and pharmacotherapy?].
Túry F
Neuropsychopharmacol Hung; 2004 Mar; 6(1):30-5. PubMed ID: 15125312
[TBL] [Abstract][Full Text] [Related]
6. [Psychopharmacology in the psychogeriatric domain: current data, problems, perspectives].
Lima CA; Eap CB; Baumann P
Rev Med Suisse Romande; 2000 Feb; 120(2):131-6. PubMed ID: 10748699
[No Abstract] [Full Text] [Related]
7. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
Kasper S; Lentner S
Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992
[No Abstract] [Full Text] [Related]
8. [Psychotherapeutic effects of psychotropic drugs: principle considerations from the psychobiologic viewpoint].
Langer G
Wien Med Wochenschr; 1986 Oct; 136(19-20):491-7. PubMed ID: 3027996
[TBL] [Abstract][Full Text] [Related]
9. [Various current problems in clinical psychopharmacology].
Smulevich AB; Panteleeva GP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1345-51. PubMed ID: 6637291
[TBL] [Abstract][Full Text] [Related]
10. Generic versus brand name drugs in psychopharmacology: a pharmacoeconomic perspective.
Emanuele E
South Med J; 2011 Oct; 104(10):715-6. PubMed ID: 21941163
[No Abstract] [Full Text] [Related]
11. The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental health.
Pleil AM
Psychopharmacol Bull; 1995; 31(4):727-34. PubMed ID: 8851646
[TBL] [Abstract][Full Text] [Related]
12. [Psychotropic drugs in pregnancy: uses and risks].
Frühwald S; Ossege M; Thau K; Lenz G
Psychiatr Prax; 1998 May; 25(3):126-33. PubMed ID: 9653781
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice.
Lagomasino IT; Dwight-Johnson M; Simpson GM
Psychiatr Serv; 2005 Jun; 56(6):649-51. PubMed ID: 15939939
[No Abstract] [Full Text] [Related]
14. [Gender based psychopharmacology: gender influence in the pharmacological treatment of mental disorders].
Usall i Rodié J
Actas Esp Psiquiatr; 2004; 32(5):307-13. PubMed ID: 15529216
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions in psychopharmacology.
Callahan AM; Fava M; Rosenbaum JF
Psychiatr Clin North Am; 1993 Sep; 16(3):647-71. PubMed ID: 8415238
[TBL] [Abstract][Full Text] [Related]
16. Psychopharmacology: clinical implications of brain neurochemistry.
Scheffer RE
Pediatr Clin North Am; 2006 Aug; 53(4):767-75. PubMed ID: 16873004
[TBL] [Abstract][Full Text] [Related]
17. [The revived neuropsychopharmacology].
Gaszner P
Neuropsychopharmacol Hung; 2005 Mar; 7(1):1-2. PubMed ID: 16167461
[No Abstract] [Full Text] [Related]
18. [Therapeutic and cosmetic psychopharmacology. Risks and limits].
Echarte Alonso LE
Cuad Bioet; 2009; 20(69):211-30. PubMed ID: 19507923
[TBL] [Abstract][Full Text] [Related]
19. [Scientific methodology and psychopharmacology].
Elie R; Ohayon M
Ann Med Psychol (Paris); 1992; 150(2-3):192-4; discussion 194-5. PubMed ID: 1343517
[No Abstract] [Full Text] [Related]
20. Child psychopharmacology.
Simeon JG
J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):695-6. PubMed ID: 1890111
[No Abstract] [Full Text] [Related]
[Next] [New Search]
